Sign In
Buy ATNM
$1.11
-0.0500 (-4.31%)
At Close: Jun 04, 2026
ImmunoGen (IMGN) Gets a Buy Rating from William Blair - Markets
09:57am, Friday, 26'th Jun 2020
William Blair analyst Andy Hsieh reiterated a Buy rating on ImmunoGen (IMGN – Research Report) on June 22. The company’s
Zacks Investment Research Upgrades Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) to “Buy”
02:00am, Wednesday, 24'th Jun 2020
Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Monday, Zacks.com reports. The firm curren
ACTINIUM PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K) | MarketScreener
09:22pm, Friday, 19'th Jun 2020Actinium Pharmaceuticals, Inc. Announces Closing of $25.0 Million Public Offering
09:15pm, Friday, 19'th Jun 2020
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or "the Company") today announced the closing of its previously announced public offering of 76,923,077 shares of its common stock (or
Is Actinium Pharmaceuticals (ATNM) Outperforming Other Medical Stocks This Year?
03:30pm, Wednesday, 17'th Jun 2020
Is (ATNM) Outperforming Other Medical Stocks This Year?
Actinium Pharmaceuticals, Inc. Announces Pricing of $25.0 Million Public Offering
03:30am, Wednesday, 17'th Jun 2020
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or "the Company") today announced the pricing of its previously announced public offering of 76,923,077 shares of its common stock (or
The Daily Biotech Pulse: Patent Win For Amarin, FDA Nod For Novartis & Merck, Chembio's Coronavirus EUA Revoked
12:00am, Wednesday, 17'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hour.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 16)
ADC Therapeutics SA (NYSE:...
Actinium Pharmaceuticals, Inc. Announces Proposed Public Offering
08:01pm, Tuesday, 16'th Jun 2020
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or "the Company") today announced that it intends to offer and sell shares of its common stock (or common stock equivalents in lieu the
Is the Options Market Predicting a Spike in Actinium Pharmaceuticals (ATNM) Stock?
03:29am, Tuesday, 16'th Jun 2020
Investors need to pay close attention to Actinium Pharmaceuticals (ATNM) stock based on the movements in the options market lately.
Is the Options Market Predicting a Spike in Actinium Pharmaceuticals (ATNM) Stock?
12:00am, Tuesday, 16'th Jun 2020
Stocks Analysis by Zacks Investment Research covering: Actinium Pharmaceuticals Inc. Read Zacks Investment Research's latest article on Investing.com
Aptose Biosciences (APTO) Receives a Buy from JonesTrading - Markets
02:51pm, Friday, 12'th Jun 2020
In a report released today, Matthew Cross from JonesTrading maintained a Buy rating on Aptose Biosciences (APTO – Research Report),
How Actinium Pharmaceuticals (ATNM) Stock Stands Out in a Strong Industry
12:43pm, Friday, 12'th Jun 2020
Actinium Pharmaceuticals (ATNM) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Actinium Pharmaceuticals (ATNM) Jumps: Stock Rises 6.7%
12:47pm, Tuesday, 09'th Jun 2020
Actinium Pharmaceuticals (ATNM) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Hedge Funds Cautiously Watching Actinium Pharmaceuticals Inc (ATNM)
01:45am, Friday, 05'th Jun 2020
In this article we will take a look at whether hedge funds think Actinium Pharmaceuticals Inc (NYSE:ATNM) is a good investment right now. We check hedge fund and billionaire investor sentiment before
